ALMOND THERAPY: TARGETING THE AMYGDALA Trademark

Trademark Overview


On Tuesday, December 21, 2021, a trademark application was filed for ALMOND THERAPY: TARGETING THE AMYGDALA with the United States Patent and Trademark Office. The USPTO has given the ALMOND THERAPY: TARGETING THE AMYGDALA trademark a serial number of 97182740. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, July 24, 2024. This trademark is owned by PsiloTec Health Solutions Inc.. The ALMOND THERAPY: TARGETING THE AMYGDALA trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Provision of education in the nature of providing courses of instruction and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education in the nature of providing courses of instruction and training in the field of psychedelic medicines

Compilation of medical data for financial purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Compilation for business purposes and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Psychotherapy services; mental health therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services

Medical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, p...
almond therapy: targeting the amygdala

General Information


Serial Number97182740
Word MarkALMOND THERAPY: TARGETING THE AMYGDALA
Filing DateTuesday, December 21, 2021
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, July 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProvision of education in the nature of providing courses of instruction and training in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of education in the nature of providing courses of instruction and training in the field of psychedelic medicines
Goods and ServicesCompilation of medical data for financial purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes
Goods and ServicesCompilation for business purposes and processing of medical data relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes
Goods and ServicesPsychotherapy services; mental health therapy for the treatment of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; provision of information to others in the field of mental health; clinical mental health counselling services
NOT AVAILABLE"THERAPY"
Goods and ServicesMedical and scientific research and development in the field of psychedelics; medical and scientific research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; laboratory research in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; providing temporary use of online, non-downloadable computer software for providing therapy services in the nature of scheduling and facilitating Internet-based patient and medical provider meetings to individuals in the field of psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes; compilation of medical data for research purposes relating to psychiatric diseases, addiction disorders, anxiety disorders, psychological trauma, physical trauma, chronic pain, cognitive diseases, neuropsychiatric disorders, sleep related disorders, mental health problems experienced by indigenous and other marginalized communities, covid-19 symptoms and syndromes

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2022
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePsiloTec Health Solutions Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2P4J8
CA

Trademark Events


Event DateEvent Description
Friday, December 24, 2021NEW APPLICATION ENTERED
Tuesday, December 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 24, 2022ASSIGNED TO EXAMINER
Tuesday, June 28, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 25, 2022SUSPENSION LETTER WRITTEN
Thursday, August 25, 2022LETTER OF SUSPENSION E-MAILED
Thursday, August 25, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 23, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 23, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 23, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 23, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 23, 2023SUSPENSION INQUIRY WRITTEN
Thursday, February 23, 2023INQUIRY TO SUSPENSION E-MAILED
Thursday, February 23, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 23, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, October 22, 2023ASSIGNED TO LIE
Monday, October 23, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 23, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 23, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2023SUSPENSION LETTER WRITTEN
Tuesday, October 24, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 22, 2024SUSPENSION INQUIRY WRITTEN
Saturday, July 20, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 20, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, July 24, 2024SUSPENSION LETTER WRITTEN
Wednesday, July 24, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 24, 2024LETTER OF SUSPENSION E-MAILED
Monday, April 22, 2024INQUIRY TO SUSPENSION E-MAILED
Monday, April 22, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, July 20, 2024TEAS/EMAIL CORRESPONDENCE ENTERED